Resmed

Resmed Debt

The Debt of Resmed (RMD) as of Oct 15, 2026 is 289.09 M USD. In the previous year, Debt was 668.29 M USD — a change of -56.74% (lower).

Debt

289.09 MUSD

YoY

-56.74%

Last updated:

In 2026, Resmed's total debt was 289.09 M USD, a -56.74% change from the 668.29 M USD total debt recorded in the previous year.

The Resmed Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
1.27 B USD
Jan 1, 2020
1.18 B USD
Jan 1, 2021
655.35 M USD
Jan 1, 2022
775.24 M USD
Jan 1, 2023
1.44 B USD
Jan 1, 2024
707.21 M USD
Jan 1, 2025
668.29 M USD
Jan 1, 2026
289.09 M USD
The Resmed Debt history
YEARDebtYoY
289.09 MUSD-56.74%
668.29 MUSD-5.50%
707.21 MUSD-50.93%
1.44 BUSD+85.90%
775.24 MUSD+18.29%
655.35 MUSD-44.28%
1.18 BUSD-7.46%
1.27 BUSD+351.47%
281.50 MUSD-73.90%
1.08 BUSD-8.03%
1.17 BUSD+290.15%
300.60 MUSD-0.07%
300.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Resmed Stock analysis

What does Resmed do? ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed is one of the most popular companies on Eulerpool.

Debt Details

Understanding Resmed's Debt Structure

Resmed's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Resmed's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Resmed’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Resmed’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Resmed stock

Debt of Resmed is 289.09 M USD in 2026.

Debt of Resmed changed from 668.29 M USD to 289.09 M USD, representing a -56.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Resmed since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Resmed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Resmed

All Key Metrics — Resmed